What is a clinical trial? Is participating in a clinical trial right for you? Learn more
Have you or your loved ones been diagnosed with hemophilia a?
You may be eligible to participate in a hemophilia a clinical trial.
Have you or your loved ones been diagnosed with hemophilia a? You may be eligible to participate in a hemophilia a clinical trial.
Active not recruiting
Male
All ages
This multicenter, open-label, phase 3 extension study will investigate the safety and efficacy of rVIII‑SingleChain for prophylaxis and on‑demand treatment of bleeding episodes in 50 previously untreated patients (PUPs) with no previous exposure to any FVIII product who achieve at least 50 EDs to rVIII-SingleChain in this study. A substudy (open to both PTPs and PUPs) will investigate the use of rVIII-SingleChain in surgery. A substudy (open to PUPs who develop an inhibitor to rVIII-SingleChain) will investigate the use of rVIII-SingleChain in immune tolerance induction (ITI) therapy.
Available locations

Study Site 7240008
Active not recruiting A Coruna, ESP 15006

Study Site 5280006
Active not recruiting Amsterdam Zuidoost, NLD 1105 AZ

Study Site 8400241
Active not recruiting Aurora, CO, USA 80045

Study Site 7640001
Active not recruiting Bangkok, THA 10330

Study Site 7640005
Active not recruiting Bangkok, THA 10700

Study Site 7240021
Active not recruiting Barcelona, ESP 08035

Study Site 4220007
Active not recruiting Beirut, LBN 165191

Study Site 2760034
Active not recruiting Bonn, DEU 53127

Study Site 2500015
Active not recruiting Brest, FRA 29609